Anticoagulant Treatment in Patients with Atrial Fibrillation and Ischemic Stroke
Atrial fibrillation (AF) is the most common cardiac dysrhythmia, with a lifetime risk of 25%, and it is a well-known independent risk factor for ischemic stroke. Over the last 15 years, efforts have been made to initiate relevant treatment in patients with AF. A retrospective study was set up to clarify whether this effort has resulted in a decreased proportion of patients with known AF experiencing an ischemic stroke.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Nicole Scheldon Brunner Frandsen, Andreas Dammann Andersen, Hamoun Ashournia, Ivan Brandslund, Jens Ole Kjærsgaard, Ole Jakob Vilholm Source Type: research